Endocarditis pathophysiology

Jump to navigation Jump to search

WikiDoc Resources for Endocarditis pathophysiology

Articles

Most recent articles on Endocarditis pathophysiology

Most cited articles on Endocarditis pathophysiology

Review articles on Endocarditis pathophysiology

Articles on Endocarditis pathophysiology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Endocarditis pathophysiology

Images of Endocarditis pathophysiology

Photos of Endocarditis pathophysiology

Podcasts & MP3s on Endocarditis pathophysiology

Videos on Endocarditis pathophysiology

Evidence Based Medicine

Cochrane Collaboration on Endocarditis pathophysiology

Bandolier on Endocarditis pathophysiology

TRIP on Endocarditis pathophysiology

Clinical Trials

Ongoing Trials on Endocarditis pathophysiology at Clinical Trials.gov

Trial results on Endocarditis pathophysiology

Clinical Trials on Endocarditis pathophysiology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Endocarditis pathophysiology

NICE Guidance on Endocarditis pathophysiology

NHS PRODIGY Guidance

FDA on Endocarditis pathophysiology

CDC on Endocarditis pathophysiology

Books

Books on Endocarditis pathophysiology

News

Endocarditis pathophysiology in the news

Be alerted to news on Endocarditis pathophysiology

News trends on Endocarditis pathophysiology

Commentary

Blogs on Endocarditis pathophysiology

Definitions

Definitions of Endocarditis pathophysiology

Patient Resources / Community

Patient resources on Endocarditis pathophysiology

Discussion groups on Endocarditis pathophysiology

Patient Handouts on Endocarditis pathophysiology

Directions to Hospitals Treating Endocarditis pathophysiology

Risk calculators and risk factors for Endocarditis pathophysiology

Healthcare Provider Resources

Symptoms of Endocarditis pathophysiology

Causes & Risk Factors for Endocarditis pathophysiology

Diagnostic studies for Endocarditis pathophysiology

Treatment of Endocarditis pathophysiology

Continuing Medical Education (CME)

CME Programs on Endocarditis pathophysiology

International

Endocarditis pathophysiology en Espanol

Endocarditis pathophysiology en Francais

Business

Endocarditis pathophysiology in the Marketplace

Patents on Endocarditis pathophysiology

Experimental / Informatics

List of terms related to Endocarditis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Altered blood flow around the valves is a risk factor for the development of endocarditis. The valves may be damaged congenitally, from surgery, by auto-immune mechanisms, or simply as a consequence of old age. The damaged part of a heart valve becomes covered with a blood clot, a condition known as non-bacterial thrombotic endocarditis (NBTE).

In a healthy individual, a bacteremia (where bacteria get into the blood stream through a minor cut or wound) would normally be cleared quickly with no adverse consequences. If a heart valve is damaged and covered with thrombus, these structures can provide a nidus for bacteria to attach themselves and an infection can be established.

The bacteremia is often caused by dental procedures, such as a cleaning or extraction of a tooth. It is important that a dentist or a dental hygienist therefore be told of any heart problems before beginning the procedure. Prophylactic antibiotics are administered to patients with certain heart conditions as a precaution.

Another cause of infective endocarditis is a scenario in which an excess number of bacteria enter the bloodstream. Colorectal cancer, serious urinary tract infections, and IV drug use can all introduce large numbers of such bacteria. When a large burden of bacteria are introduced, a normal heart valve may be infected. A more virulent organism (such as Staphylococcus aureus, but see below for others) is often responsible for infecting a normal valve.

Infections of the tricuspid valve and less frequently the pulmonic valve tend to occur in intravenous drug users given the high pathogen burden from their introduction in the vein. The diseased valve is most commonly affected when there is a pre-existing disease. In rheumatic heart disease this is the aortic valve and the mitral valves, on the left side of the heart.

Complications of endocarditis can occur as a result of the locally destructive effects of the infection. These complications include perforation of valve leaflets, perforation of fistula between blood vessels or cardiac chambers, abscesses, embolization and disruption of conduction system.

References

Template:WH Template:WS